You are here

OPKO Health

Pfizer partner Opko reports a PhIII failure for growth hormone, but tries to steer out of a crash

Endpoints

Fri, 12/30/16 - 10:34 am

clinical trials

4 US pharma execs make Forbes 400 list

BioPharma Dive

Wed, 10/19/16 - 06:47 pm

Patrick Soon-Shiong

Opko wins approval for kidney drug after manufacturing snag

BioPharma Dive

Thu, 06/23/16 - 08:13 pm

secondary hyperparathyroidism

OPKO Health posts first-quarter loss of $12 million

Yahoo/AP

Mon, 05/9/16 - 09:50 pm

Top 6 Biopharma Movers of the Past Week

24/7 Wall St

Mon, 04/4/16 - 07:56 am

Genocea Biosciences

Apricus Biosciences

Opko Health stock falls 10% after drug approval faces delay

Bizjournals.com

Wed, 03/30/16 - 09:21 pm

5 Key FDA Decisions Expected in March

24/7 Wall St

Mon, 03/14/16 - 10:02 am

Alder Biopharmaceuticals

3 Biotech Companies With Recent Large Insider Buying

Yahoo/Benzinga

Wed, 03/2/16 - 10:54 am

Seattle Genetics

Intra-Cellular Therapies

Opko Health's New Era Begins

Motley Fool

Sat, 11/21/15 - 12:26 pm

chronic kidney disease

5 Big FDA Decisions Expected in September

24/7 Wall St

Sun, 08/30/15 - 02:08 pm

Apricus Biosciences

FDA Accepts OPKO’s New Drug Application for Rayaldee

Yahoo

Wed, 07/29/15 - 10:10 am

secondary hyperparathyroidism

Pfizer's Next-Generation Human Growth Hormone Takes a Step Forward

Motley Fool

Sat, 07/11/15 - 10:30 am

human growth hormone

human growth hormone deficiency

The Biotech Drug Lord: How One Man Is Conquering The Biotech Space

Motley Fool

Sun, 06/28/15 - 11:47 am

The latest healthcare merger has sent this stock through the roof

Yahoo/Business Insider

Thu, 06/4/15 - 11:36 am

BioReference Labs

An Attractive M&A Play In The Busy Biotech Space

Forbes

Thu, 05/14/15 - 09:55 am

Pfizer, Inc. Invests in Growth... Literally

Motley Fool

Wed, 12/17/14 - 08:26 am

human growth hormone

OPKO and Pfizer Enter into Global Agreement for OPKO’s Long-Acting Human Growth Hormone (hGH-CTP)

Yahoo

Mon, 12/15/14 - 08:23 am

human growth hormone

Biotech's 3 Most Influential CEOs

Motley Fool

Thu, 11/20/14 - 10:54 am

Teva Pharmaceutical

Chris Viehbacher

Gilead Sciences

Morning Movers in Biotech: Medicines Co., Omeros Corporation, Opko Health, Inc. and VIVUS, Inc.

Motley Fool

Thu, 04/3/14 - 09:21 am

Medicines Company

Zerenex- The New Spark For Keryx?

Seeking Alpha

Mon, 11/25/13 - 10:57 am

Pages